| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |